- Maximizing Compound Value
| Chairs: |
Christopher Lipinski (Melior Discovery, US);
Ian Yates (Velocity11, US);
Hubert Haag (Sanofi-Aventis, DE) |
- Drug Discovery Technologies
| Chairs: |
Andrea Chow (Caliper Life Sciences, US);
Al Kolb (KeyTech Solutions, US);
Lorenz Mayr (Novartis Pharma, CH) |
- Structure-Based Drug Design
| Chairs: |
Ruben Abagyan (The Scripps Research Institute, US);
Alexander Hillisch (Bayer Healthcare, DE) |
- Drug Discovery Processes
| Chairs: |
Kurt Amrein (F. Hoffmann-La Roche, CH);
William Janzen (Amphora Discovery, US);
Thilo Enderle (F. Hoffmann-La Roche, CH) |
- Pharmacodynamics and Biomarkers
| Chairs: |
Eric Bertrand (Novartis Pharma, CH);
Roy Goodacre (University of Manchester, UK);
Melvin Reichman (Lankenau Institute for Medical Research, US) |
- Emerging ADME/Tox Technologies
| Chairs: |
Melvin Reichman (Lankenau Institute for Medical Research, US)
Wolfgang Sauer (Merck Serono International S.A, CH) |
|